European Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by All Financing Schemes Share by Country (Million Euros)

In 2023, Germany led European healthcare expenditure on pharmaceuticals and medical non-durable goods with a share of 25.94 million euros, followed by France at 14.55 million euros and Italy at 11.24 million euros. Over the past year, significant growth was observed in countries like Portugal (7.54%), Romania (6.78%), and Lithuania (6.48%). Malta reported an impressive 21.32% increase. Conversely, Norway experienced a slight decline. The average compound annual growth rate (CAGR) across these countries remains robust, signifying sustained spending increases over time.

Future trends to watch include increasing investments in digital health solutions and personalized medicine, rising demand for generic and biosimilar medications, and efforts to achieve more sustainable healthcare systems amid demographic shifts and ongoing regulatory transformations.